CBD Oil in Hemp Seed Oil (30%)
CBD Oil in Hemp Seed Oil (30%) Black is backordered and will ship as soon as it is back in stock.
CBD oil in hemp seed oil (30%)
Natural THC-free broad-spectrum cannabidiol produced in Switzerland
Our CBD oil in hemp seed oil is a high-quality natural product made with broad-spectrum cannabidiol (CBD) obtained from certified Swiss hemp, carefully extracted to preserve the most valuable components. The oil is completely free of THC (tetrahydrocannabinol), and each bottle contains a medical pipette for accurate and easy dosing. This CBD oil is suitable for those who want natural products without artificial colourings, pesticides, herbicides, nicotine or chemical residues.
Benefits and effects of CBD oil in hemp seed oil
CBD oil can contribute to a number of health benefits and has been used to support the body's natural balance and well-being. CBD can be soothing and calming and contributes to healthier skin, and the hemp seed oil in this formulation naturally provides omega-3 and omega-6 fatty acids, vitamins and minerals such as vitamin E. The combination of CBD and hemp seed oil can provide moisture to the skin, helping to maintain elasticity and reduce dryness. Important: This oil is intended for cosmetic use and application to the skin, not for oral use.
Ingredients and contents
- Ingredients: Hemp seed oil (omega-3 and omega-6 fatty acids, minerals and vitamin E), CBD oil (3000 mg cannabidiol from broad-spectrum Swiss hemp)
- The laboratory test: 0.0% THC, completely free of heavy metals, solvents and pesticides.
- Contents per bottle: 10 ml of CBD oil, corresponds to approximately 270 drops.
Instructions for use
Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening, especially on dry or irritated skin. We recommend starting with a low dose, especially if you are new to CBD products. Store the product in a cool, dry place out of direct sunlight to preserve the quality of the oil.
Test results and quality assurance
This product has been thoroughly tested in Switzerland, both for cannabinoid content and microbiological safety. Our strict quality control ensures that the product meets the market's strictest requirements for purity and consistency. All batches of CBD oil are analyzed to document both cannabinoid content, microbiological safety, absence of heavy metals and residual solvents.
Reservation
Allowed to be used by adults over 18 years of age. Not suitable for pregnant or breastfeeding women. Always consult a doctor before use if you have a medical condition or are taking prescription medication. This product is for cosmetic use only. Uno Vita does not claim that the product can cure disease or have other medical effects. CBD cosmetics can be beneficial for dry and irritated skin.
Freedom of expression and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like. We do this with reference to national and international laws on freedom of expression and belief, including:
- United Nations Universal Declaration of Human Rights (1948): Article 19 ensures the right to freedom of opinion and expression, including the freedom to receive and impart information regardless of frontiers.
- The International Covenant on Civil and Political Rights (1966): Article 19 emphasizes the right to freedom of expression and the freedom to seek, receive and impart information and ideas through various media.
- Norwegian Constitution § 100: Ensures freedom of expression, with certain limitations for reasons of child protection, privacy, public order and safety.
- America's First Amendment: Protects freedom of speech against government interference, and provides one of the strongest protections for free speech.
Uno Vita reserves the right to freedom of opinion and expression in line with these principles.
Relevant references:
- Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics.
- Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
- Ashton, C.H. (2001). Pharmacology and effects of cannabis: A brief review.
- Mechoulam, R., & Parker, L.A. (2013). The endocannabinoid system and the brain.
- Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
- Pertwee, R.G. (2006). Cannabinoid pharmacology: the first 66 years.
- Schicho, R., & Storr, M. (2012). Cannabis finds its way into the treatment of Crohn's disease.
- Pamplona, F.A., et al. (2018). The anti-inflammatory properties of cannabidiol (CBD).
- Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep: A large case series.
- McPartland, J.M., et al. (2015). Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system?
- Zuardi, A.W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with a wide spectrum of action.
- Pisanti, S., et al. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications.
